Avadel Pharmaceuticals
(NASDAQ:AVDL)
$16.8999
1.0699[6.76%]
At close: May 10
$16.8999
0[0.00%]
After Hours: 5:56PM EDT
Q1 2024 Earnings were released on Wed May 8th, before the market open
The most recent conference call was at 8:30 AM, 2 days ago Click to view past webcast

Avadel Pharmaceuticals Stock (NASDAQ:AVDL), Earnings Estimates, EPS, and Revenue

Avadel Pharmaceuticals reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.

Earnings Date
May 8
EPS
$-0.300
Quarterly Revenue
$27.2M
Annual Revenue
(as of Dec 31)
$28M

Analyze the earnings history of Avadel Pharmaceuticals using advanced sorting and filters.

No data available to display
ticker
▲▼
Company Name
▲▼
Prior EPS
▲▼
Est EPS
▲▼
Actual EPS
▲▼
EPS Surprise
▲▼
Prior Rev
▲▼
Est Rev
▲▼
Actual Rev
▲▼
Rev Surprise
▲▼
Date
▲▼
Get Alert

FAQ

Q

When is Avadel Pharmaceuticals (NASDAQ:AVDL) reporting earnings?

A

Avadel Pharmaceuticals (AVDL) is scheduled to report earnings on August 7, 2024. The last reported earnings were for reported on May 8, 2024 for Q1.

Q

What were the latest earnings per share (EPS) for Avadel Pharmaceuticals (NASDAQ:AVDL)?

A

The Actual EPS was $-0.30, which missed the estimate of $-0.21.

Q

What were Avadel Pharmaceuticals’s (NASDAQ:AVDL) revenues?

A

The Actual Revenue was $27.2M, which beat the estimate of $26.7M.

Browse earnings estimates, EPS, and revenue on all stocks.